Related News

May 13, 2020

SmarTrend identified an Uptrend for Myriad Genetics (NASDAQ:MYGN) on March 24th, 2020 at $13.36. In approximately 2 months, Myriad Genetics has returned 6.70% as of today's recent price of $14.25.

In the...

April 28, 2020

SmarTrend identified an Uptrend for Myriad Genetics (NASDAQ:MYGN) on March 24th, 2020 at $13.36. In approximately 1 month, Myriad Genetics has returned 12.62% as of today's recent price of $15.04.

Myriad...

April 12, 2020

Below are the three companies in the Biotechnology industry with the lowest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Pdl Biopharma In ranks...

March 31, 2020

Below are the three companies in the Biotechnology industry with the lowest sales growth.

Myriad Genetics ranks lowest with a sales growth of 233.5%. Following is Genomic Health I with a sales growth of 392.9%. Biospecifics Tec ranks...

March 17, 2020

SmarTrend identified a Downtrend for Myriad Genetics (NASDAQ:MYGN) on February 7th, 2020 at $20.17. In approximately 1 month, Myriad Genetics has returned 48.38% as of today's recent price of $10.41.

Myriad...

March 17, 2020

Below are the three companies in the Biotechnology industry with the lowest projected earnings growth. The growth of earnings per share (current fiscal year estimated vs. last year actual) is important to gauge future profitability and relative...

February 19, 2020

Below are the three companies in the Biotechnology industry with the lowest projected earnings growth. The growth of earnings per share (current fiscal year estimated vs. last year actual) is important to gauge future profitability and relative...

February 7, 2020

Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $19.08 to a high of $20.99. Yesterday, the shares fell 29.3%, which took the trading range below the 3-day low of $28.14 on...

February 7, 2020

Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $19.08 to a high of $20.99. Yesterday, the shares fell 29.3%, which took the trading range below the 3-day low of $28.14 on...

February 7, 2020

SmarTrend identified an Uptrend for Myriad Genetics (NASDAQ:MYGN) on January 15th, 2020 at $29.32. In approximately 3 weeks, Myriad Genetics has returned 0.61% as of today's recent price of $29.50.

In the...